See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Integra LifeSciences Holdings Corporation (IART) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Integra LifeSciences Holdings Corporation (IART) - free report >>
Image: Bigstock
Integra (IART) Catches Eye: Stock Adds 6% in Session
Integra LifeSciences Holdings Corporation (IART - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The upside was driven by the company’s announcement of better-than-expected earnings and revenues for the third quarter of 2016. This led to solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down nearly 3.4% in the past one-month time frame.
In the last 30 days, the company witnessed five positive estimate revisions and the Zacks Consensus Estimate also moved higher over the same time frame, suggesting that more solid trading could be ahead for Integra. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Integra currently has a Zacks Rank #3 (Hold).
INTEGRA LIFESCI Price
INTEGRA LIFESCI Price | INTEGRA LIFESCI Quote
A better-ranked stock in the Med-Biomed/Gene industry is Anika Therapeutics Inc. (ANIK - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here
Is IART going up? Or down? Predict to see what others think: Up or Down
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>